Cross-sectional survey shows associations between coffee intake and liver cancer risk across demographic factors, suggesting protective effects.
Coffee consumption has drawn increasing attention for its possible protective belongings against liver cancer, especially among high-risk populations. This research was designed to thoroughly examine the association among coffee intake and liver cancer risk diagonally diverse demographic groups. A cross-sectional survey involving 300 participants was conducted, collecting data on key variables, including age, smoking, alcohol consumption, and levels of coffee intake. Statistical analyses were accomplished utilizing SPSS software, employing logistic regression and chi-square tests to inspect the associations among coffee consumption, demographic factors, and liver cancer risk. The outcomes exposed that higher quantity of coffee intake were crucially linked to a reduced risk of liver cancer compared to lower consumption levels, suggesting a possible dose-response relationship. Among the demographic factors analyzed, age emerged as a substantial risk factor for liver cancer, with older individuals evincing a higher likelihood of expanding the disease. Additionally, smoking and alcohol consumption were recognized as significant lifestyle behaviors providing to liver cancer risk, further emphasizing the complicated nature of the disease. These findings highlight coffee’s possible as a protective dietary intervention for commuting liver cancer risk, especially in populations at greater risk due to age or other lifestyle factors. The study emphasizes the importance of incorporating coffee consumption into broader dietary and public health approaches for cancer prevention. Moreover, it advocates for further research to unravel the mechanisms underlying coffee’s protective effects and to advance adjusted dietary and lifestyle recommendations aimed at appreciably reducing liver cancer risk, eventually promoting improved health outcomes in unprotected populations.
No takes yet. Share an insight, caveat, or question.
Mathapati et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: